Dear Colleagues,

The French-Brazilian Oncology Society and the Association Franco-Brésilienne de Cancérologie organize a biennial multidisciplinary oncology conference. The first was held in 2002, in Rio de Janeiro, Brazil.

The upcoming congress, in 2008, will bring together more than forty French and American speakers, as well as 700 Brazilian physicians. All speeches and lectures will have simultaneous translation in Portuguese, French and English.

Our partnership with ASCO (American Society of Clinical Oncology), established in 2006, will continue with an “Advanced course” in one day during the 2008 meeting with speakers from ASCO, with simultaneous translation in English, French and Portuguese.

Two months after the 33rd European Society of Medical Oncology Congress in Sweden, the SFBO Congress will include in its congress a “Best of ESMO” session, the official post ESMO meeting.

The 5th SFBO Congress will be held in five different rooms and will cover the following topics:
1) Vth French-Brazilian Oncology Congress Program

Breast Cancer
Lung Cancer
Prostate Cancer
Gastrointestinal Cancer
Gynecological Cancer
Sarcoma
New Drugs
Hematology-Oncology
Cancer Prevention and Control

2) IInd ASCO/SFBO JOINT SYMPOSIUM

3) IInd BEST OF ESMO

4) Ist FRANCOPHONE BREAST CANCER COURSE

This course will be a novelty in the field of oncology. It will be interactive and include all specialties required for the treatment of breast cancer. Anatomical pathology, histopathology, radiology, breast and plastic surgery, clinical oncology and radiotherapy will be discussed.

5) IVth French-Brazilian Radiotherapy Seminar

This seminar is not designed solely for radiation oncologists, but for all health professionals who act as partners in the field of oncology. The purpose is to show the interdisciplinary nature of this specialty.

Many important innovations have occurred in the last few years in radiotherapy and it is important to keep the clinical community updated about them.

6) IIIrd Thoracic Surgery Seminar

This surgery seminar is not designed solely for surgeons and will be open to all health professionals interested in lung cancer treatment.

7) IInd Psychology Oncology Seminar

The purpose of this seminar is to develop a global treatment approach, in which the emotional state of the patient as well as the psychological support given to the patient and the family is taken into account.

Professor Jean Bourhis

Head, of the Radiotherapy Department at the Gustave Roussy Institute Villejuif-Paris France
President, Groupe Oncologie Radiotherapie Tête e Cou (GORTEC).
Professor of Oncology, at the Paris XI University.

Professor Aimery de Gramont

Professor of Oncology at the Paris VI University
Head of the Oncology Department at Saint-Antoine Hospital, in Paris, France
Chair of the, Multidisciplinary Cancer Research Group (GERCOR), Gynecological and GI tract cancer therapy.
Cochairman, Scientific Board of the International Society of Gastrointestinal Oncology
Editorial Board Member of the Journal of Clinical Oncology 2003-2005
Chairman, International MOSAIC Protocol
Chairman, International C99 OPTIMOX Protocol
Chairman, ongoing International AVANT Protocol
Cochairman, ongoing International DREAM Protocol
Chairman, French C91 Intergroup Protocol
Chairman, International C95 Protocol
Chairman, National C97 Protocol
180 published works in journals and 250 papers with editorial review (2007) Topics: Treatment in GI tract cancers and ovarian cancer.

Vice-Chair, of the French Sarcoma/GETO Group and of the Bone and Soft Tissue Sarcoma Group (BSTSG) of the EORTC (European Organization for Research and Treatment of Cancer).
Author of more than 100 research publications on sarcoma, lung and breast cancer, immunotherapy and gene therapy.

Professor Moise Namer

Professor of Oncology at the University of Medicine of Nice.
Chairman of the Breast Pathology Committee of the National Cancer Institute in France (INCA).
Chairman of the Breast Cancer Guidelines of Saint Paul de Vence France.

Professora Martine Piccart

Professor of Oncology, “Université libre de Bruxelles”, in Brussels Belgium.
Head, of the Oncology Department at the Jules-Bordet Institute in Brussels Belgium.
EORTC President
Chairman of the Breast International Group (BIG).
Principal investigator of many ongoing International clinical trials and at the Jules Bordet Institute, (TRANSBIG, HERA study etc..)
Scientific board member of many organizations (ASCO, AACR, ESMO, EORTC).
Author and coauthor of more than 200 scientific Intrnational publications.

Professor Jean-Charles Soria

Professor of Medicine and Clinical Oncology at the Paris XI University.
Head of the Phase I Programs of the Lung Cancer Unit with emphasis on target therapies at the Gustave Roussy Institute Villejuif-Paris France in charge of the National Scientific Program (PNES) of the French NCI (INCA). Board member of ASCO Educational Committee (American Society of Clinical Oncology) and ESMO (European Society of Medical Oncology). Editorial Boards Member of Clinical Oncology Journal, The Lancet Oncology, The American Journal of Clinical Oncology and the Bulletin du Cancer.

Professor Thomas Tursz

Professor of Clinical Oncology at the Paris XI University
Director of the Gustave-Roussy Villejuif-Paris France
President of the National Federation of Centers Against Cancer (Fédération Nationale des Centres de Lutte Contre le Cancer (F.N.C.L.C.C.).
Director of the Federal European Cancer School
Chairman of the European Cancer Institutes Organization (OECI).
Author of more than 200 research publicationsin immunotherapy and gene therapy